Tumor-infiltrating lymphocytes: evidence for specific immune reactions against growing cancers in mice and humans.
Topalian
S L
SL
Rosenberg
S A
SA
D000818:Animals; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D002478:Cells, Cultured; D002634:Chemotaxis, Leukocyte; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007116:Immunization, Passive; D007376:Interleukin-2 / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000473:pathology* / Q000628:therapy; D009374:Neoplasms, Experimental / Q000276:immunology / Q000473:pathology* / Q000628:therapy; D011994:Recombinant Proteins / Q000494:pharmacology; D012075:Remission, Spontaneous; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology* / Q000637:transplantation
D000945:Antigens, Differentiation, T-Lymphocyte; D007376:Interleukin-2; D011994:Recombinant Proteins